Drug Shortage Report for CIPRO ORAL SUSPENSION
Report ID | 180743 |
Drug Identification Number | 02237514 |
Brand name | CIPRO ORAL SUSPENSION |
Common or Proper name | Ciprofloxacin Suspension |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100 mL |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-03-06 |
Actual start date | |
Estimated end date | 2023-03-10 |
Actual end date | 2023-03-03 |
Shortage status | Avoided shortage |
Updated date | 2023-03-06 |
Company comments | Supply Constraints |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-01-12 | English | Compare |
v2 | 2023-01-12 | French | Compare |
v3 | 2023-02-06 | English | Compare |
v4 | 2023-02-06 | French | Compare |
v5 | 2023-02-17 | English | Compare |
v6 | 2023-02-17 | French | Compare |
v7 | 2023-03-06 | English | Compare |
v8 | 2023-03-06 | French | Compare |
Showing 1 to 8 of 8